Protective Effects of Molsidomine Against Cisplatin-Induced Nephrotoxicity


Creative Commons License

Karakoc H. , Altintas R., PARLAKPINAR H., Polat A., ŞAMDANCI E., Sagir M., ...More

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, vol.24, no.4, pp.585-593, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 4
  • Publication Date: 2015
  • Doi Number: 10.17219/acem/58970
  • Title of Journal : ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
  • Page Numbers: pp.585-593

Abstract

Background. Cisplatin, an effective chemotherapeutic agent, is used for the treatment of several types of cancers. However, cisplatin has some severe side effects such as nephrotoxicity. On the other hand, molsidomine, a NO donor, has anti-oxidative and vasodilator effects.